Insider Trading & Ownership of JONATHAN G. DRACHMAN

Location: Bothell, WA
Summary: The estimated net worth of JONATHAN G. DRACHMAN is at least $1,701,890 dollars as of 11 Mar 2024. JONATHAN G. DRACHMAN is the President and CEO, Director of Neoleukin Therapeutics, Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $1.59M. JONATHAN G. DRACHMAN is the Director of Calithera Biosciences, Inc. and owns shares of Calithera Biosciences, Inc. stock worth about $77.2K. JONATHAN G. DRACHMAN is the Director of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $32.2K.
Signature: /s/ Frank J. Lanza, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when JONATHAN G. DRACHMAN files a new Insider Trading report.

Ownership of JONATHAN G. DRACHMAN

Symbol	Company	Relationship	Holdings Value	Report Period
NGNE	Neoleukin Therapeutics, Inc.	President and CEO, Director	$1,592,530	02 Aug 2022
CALA	Calithera Biosciences, Inc.	Director	$77,160	10 Nov 2021
HARP	Harpoon Therapeutics, Inc.	Director	$32,200	08 Mar 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.